B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
about
CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's LymphomasCD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesisA Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering.Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interactionA capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells.Murine models of B-cell lymphomas: promising tools for designing cancer therapiesPax genes in embryogenesis and oncogenesis.Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop.c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster.Paired box gene 5 may modulate Proviral Integration of Moloney virus 2 gene and protein expression in mature B-cells.EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.Evaluation of Pax5 expression and comparison with BLA.36 and CD79αcy in feline non-Hodgkin lymphoma.
P2860
Q26749139-64B5E099-A83B-4174-985A-3A8CB0C4C281Q28265732-2A3FC445-6FD5-4404-80CF-9814EC54955BQ33483135-BD72DC5F-EAE4-4836-85EB-A2ABF639681EQ34707190-853B21DB-15B7-43A9-98C0-BFDEF29C7B9FQ34775356-4DD1C1C8-0A44-4604-983B-CC907F4F5F5EQ35006755-D8B29BCE-1D02-404B-8F8C-8B2626C7BD1FQ35779492-B275B69A-BE88-4E3C-A0DE-FD68D0B4B03EQ35886629-BCDD3E45-DE6A-4E72-B1D9-4A7E553FA9F4Q36349583-F16ABF46-CACA-413C-9622-B82CDE325B94Q36924016-DD7046C1-0C98-4EF5-BC64-7A87306CB815Q37019606-3455B149-3100-43FB-9122-96F0A3A77463Q37381683-783D0976-F46A-4D28-84C3-C65610380E66Q37405472-A58014B4-1BD5-4570-B891-E7B9F08979C4Q37439625-D83FC76E-B593-4DA4-BE56-E8EE1E4755BDQ39596708-A62F2523-B332-4D41-9865-9A817124059EQ41464136-C5B2398E-0181-4734-89C9-5DABAD1056E2Q51557315-DAF24391-F03B-489C-B620-DAEBB25B6447
P2860
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@ast
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@en
type
label
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@ast
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@en
prefLabel
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@ast
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@en
P2093
P2860
P356
P1476
B cell activator PAX5 promotes ...... of B cell receptor signaling.
@en
P2093
Andrei Thomas-Tikhonenko
Anna Azvolinsky
Diana Cozma
Jan Erikson
Jennifer Paterson
John G Monroe
John W Tobias
Michael L Atchison
Michele H Metzgar
P2860
P304
P356
10.1172/JCI30842
P407
P577
2007-09-01T00:00:00Z